Keyphrases
Fatty Acid Synthase
100%
Endometrial Cancer Cell Line
100%
Orlistat
100%
Endometrial Cancer
27%
Apoptosis
18%
Cell Proliferation
18%
Reactive Oxygen Species
18%
Decreased Expression
18%
Cell Cycle Progression
18%
Fatty Acid Metabolism
18%
Western Immunoblotting
18%
G1 Arrest
18%
Cancer Treatment
9%
Obesity
9%
Tumorigenic Potential
9%
Cell Growth
9%
MTOR Pathway
9%
Cellular Stress
9%
Potent Inhibitor
9%
Dose Effect
9%
Immunoblot Analysis
9%
Annexin V Assay
9%
Carnitine Palmitoyltransferase 1A (CPT1A)
9%
Phosphorylated Akt
9%
MTT Assay
9%
Lipolytic Enzymes
9%
DCFH-DA
9%
KLE Cells
9%
Acetyl-CoA Carboxylase
9%
Weight Loss Medication
9%
Phosphorylated AMPK
9%
AMPK-mTOR Pathway
9%
Cellometer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
100%
Fatty Acid Synthase
100%
Tetrahydrolipstatin
100%
Western Blot
18%
Fatty Acid
18%
Reactive Oxygen Metabolite
18%
Acetyl-CoA
9%
Lipocortin 5
9%
Carboxylase
9%
Carnitine Palmitoyltransferase
9%